tiprankstipranks
Trending News
More News >
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
US Market
Advertisement

Biodexa Pharmaceuticals (BDRX) Financial Statements

Compare
508 Followers

Biodexa Pharmaceuticals Financial Overview

Biodexa Pharmaceuticals's market cap is currently $467.35K. The company's EPS TTM is $-0.007; its P/E ratio is ―; Biodexa Pharmaceuticals is scheduled to report earnings on April 11, 2025, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 0.00£ 381.00K£ 699.00K£ 578.00K£ 343.00K
Gross Profit£ -5.44M£ -3.69M£ -4.41M£ -4.08M£ -5.72M
Operating Income£ -9.20M£ -8.01M£ -8.93M£ -7.00M£ -10.67M
EBITDA£ -9.08M£ -7.16M£ -7.39M£ -5.66M£ -22.22M
Net Income£ -5.73M£ -7.08M£ -7.66M£ -5.46M£ -22.19M
Balance Sheet
Cash & Short-Term Investments£ 1.67M£ 5.97M£ 2.84M£ 10.06M£ 7.55M
Total Assets£ 14.78M£ 10.54M£ 5.53M£ 12.91M£ 9.82M
Total Debt£ 727.00K£ 464.00K£ 624.00K£ 766.00K£ 260.00K
Net Debt£ -942.00K£ -5.51M£ -2.21M£ -9.29M£ -7.29M
Total Liabilities£ 6.46M£ 5.86M£ 2.36M£ 2.46M£ 3.10M
Stockholders' Equity£ 8.32M£ 4.68M£ 3.16M£ 10.45M£ 6.72M
Cash Flow
Free Cash Flow£ -13.04M£ -7.09M£ -7.11M£ -6.33M£ -9.51M
Operating Cash Flow£ -12.26M£ -6.83M£ -7.05M£ -6.01M£ -9.30M
Investing Cash Flow£ -598.00K£ -265.00K£ -220.00K£ -278.00K£ 2.57M
Financing Cash Flow£ 8.56M£ 10.23M£ 47.00K£ 8.80M£ 3.08M
Currency in GBP

Biodexa Pharmaceuticals Earnings and Revenue History

Biodexa Pharmaceuticals Debt to Assets

Biodexa Pharmaceuticals Cash Flow

Biodexa Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis